Proof of Concept: "Bottom's Up" Seat to Treat Constipation

Sponsor
Mayo Clinic (Other)
Overall Status
Completed
CT.gov ID
NCT02419924
Collaborator
(none)
12
1
1
20
0.6

Study Details

Study Description

Brief Summary

Supporting the pelvic floor can reduce symptoms of constipation in patients with refractory constipation due to pelvic floor laxity and excessive perineal descent by means of a modified toilet seat, known as "the Bottom's Up".

Condition or Disease Intervention/Treatment Phase
  • Device: "the Bottom's Up"
N/A

Detailed Description

Efficacy and safety of a unique pelvic floor support device that fits into the Radiology defecography commode will be tested. Patients with refractory constipation due to known pelvic floor laxity and/or excessive perineal descent will be examined without, then with the device in place. Patients will complete questionnaires pertaining to device safety and efficacy before and after using the device. Radiographic images to document efficacy of support plus adequate emptying will be acquired during the study resulting in very low dose radiation exposure.

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Proof of Concept: A Commode Assist Device for Excessive Perineal Descent
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Dec 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental

Pelvic floor support device to treat refractory constipation.

Device: "the Bottom's Up"
A modified toilet seat that supports the perineum, preventing excessive pelvic floor descent and laxity which can cause constipation.
Other Names:
  • Pelvic floor support device to treat refractory constipation
  • Outcome Measures

    Primary Outcome Measures

    1. Adverse Events [through study completion, approximately one day]

      The number of participants to report adverse events.

    Secondary Outcome Measures

    1. Sense of Staining [post-defecography test, approximately 1 day]

      Sense of straining was measured using the self-reported answer to the modified Pelvic Floor Distress Inventory Questionnaire-20 (PFDI-20) question of 'Did you need to strain hard to empty your rectum'. The Likert scale questionnaire scores ranged from 0-10 where 0 = No, not at all and 10 = Yes, quite a bit.

    2. Ease of Evacuation [post-defecography test, approximately 1 day]

      Ease of evacuation was measured using the self-reported answer to the modified Pelvic Floor Distress Inventory Questionnaire-20 (PFDI-20) question of 'Did you experience pain/discomfort when you emptied your rectum'. The Likert scale questionnaire scores ranged from 0-10 where 0 = No, not at all and 10 = Yes, quite a bit.

    3. Completeness of Evacuation [post-defecography test, approximately 1 day]

      Completeness of evacuation was measured using the self-reported answer to the modified Pelvic Floor Distress Inventory Questionnaire-20 (PFDI-20) question of 'Did you feel that you completely emptied your rectum during this test'. The Likert scale questionnaire scores ranged from 0-10 where 0 = No, not at all and 10 = Yes, quite a bit.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    10 Males and female subjects greater that 18 years of age with aggravated constipation due to pelvic floor laxity of at least 4 cm and excessive perineal descent of at least 4 cm will be evaluated.

    Patients with constipation but no excessive laxity or descent will not be evaluated. Patients must be willing to sign consent, undergo defecography with and without "The Bottom's Up" device.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Clinic in Arizona Scottsdale Arizona United States 85259

    Sponsors and Collaborators

    • Mayo Clinic

    Investigators

    • Principal Investigator: Amy Foxx-Orenstein, DO, Mayo Clinic

    Study Documents (Full-Text)

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT02419924
    Other Study ID Numbers:
    • 14-009864
    First Posted:
    Apr 17, 2015
    Last Update Posted:
    Sep 2, 2020
    Last Verified:
    Aug 1, 2020
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail
    Arm/Group Title Experimental
    Arm/Group Description Pelvic floor support device to treat refractory constipation. "the Bottom's Up": A modified toilet seat that supports the perineum, preventing excessive pelvic floor descent and laxity which can cause constipation.
    Period Title: Overall Study
    STARTED 12
    COMPLETED 12
    NOT COMPLETED 0

    Baseline Characteristics

    Arm/Group Title Experimental
    Arm/Group Description Pelvic floor support device to treat refractory constipation. "the Bottom's Up": A modified toilet seat that supports the perineum, preventing excessive pelvic floor descent and laxity which can cause constipation.
    Overall Participants 12
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    54
    (18.4)
    Sex: Female, Male (Count of Participants)
    Female
    12
    100%
    Male
    0
    0%
    Race and Ethnicity Not Collected (Count of Participants)
    Region of Enrollment (Count of Participants)
    United States
    12
    100%

    Outcome Measures

    1. Primary Outcome
    Title Adverse Events
    Description The number of participants to report adverse events.
    Time Frame through study completion, approximately one day

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Experimental
    Arm/Group Description Pelvic floor support device to treat refractory constipation. "the Bottom's Up": A modified toilet seat that supports the perineum, preventing excessive pelvic floor descent and laxity which can cause constipation.
    Measure Participants 12
    Count of Participants [Participants]
    0
    0%
    2. Secondary Outcome
    Title Sense of Staining
    Description Sense of straining was measured using the self-reported answer to the modified Pelvic Floor Distress Inventory Questionnaire-20 (PFDI-20) question of 'Did you need to strain hard to empty your rectum'. The Likert scale questionnaire scores ranged from 0-10 where 0 = No, not at all and 10 = Yes, quite a bit.
    Time Frame post-defecography test, approximately 1 day

    Outcome Measure Data

    Analysis Population Description
    Two subjects did not complete the questionnaire
    Arm/Group Title Experimental
    Arm/Group Description Pelvic floor support device to treat refractory constipation. "the Bottom's Up": A modified toilet seat that supports the perineum, preventing excessive pelvic floor descent and laxity which can cause constipation.
    Measure Participants 10
    Mean (Standard Deviation) [score on a scale]
    6.1
    (2.8)
    3. Secondary Outcome
    Title Ease of Evacuation
    Description Ease of evacuation was measured using the self-reported answer to the modified Pelvic Floor Distress Inventory Questionnaire-20 (PFDI-20) question of 'Did you experience pain/discomfort when you emptied your rectum'. The Likert scale questionnaire scores ranged from 0-10 where 0 = No, not at all and 10 = Yes, quite a bit.
    Time Frame post-defecography test, approximately 1 day

    Outcome Measure Data

    Analysis Population Description
    Two subjects did not complete the questionnaire
    Arm/Group Title Experimental
    Arm/Group Description Pelvic floor support device to treat refractory constipation. "the Bottom's Up": A modified toilet seat that supports the perineum, preventing excessive pelvic floor descent and laxity which can cause constipation.
    Measure Participants 10
    Mean (Standard Deviation) [score on a scale]
    2.9
    (3.4)
    4. Secondary Outcome
    Title Completeness of Evacuation
    Description Completeness of evacuation was measured using the self-reported answer to the modified Pelvic Floor Distress Inventory Questionnaire-20 (PFDI-20) question of 'Did you feel that you completely emptied your rectum during this test'. The Likert scale questionnaire scores ranged from 0-10 where 0 = No, not at all and 10 = Yes, quite a bit.
    Time Frame post-defecography test, approximately 1 day

    Outcome Measure Data

    Analysis Population Description
    Two subjects did not complete the questionnaire
    Arm/Group Title Experimental
    Arm/Group Description Pelvic floor support device to treat refractory constipation. "the Bottom's Up": A modified toilet seat that supports the perineum, preventing excessive pelvic floor descent and laxity which can cause constipation.
    Measure Participants 10
    Mean (Standard Deviation) [score on a scale]
    5.3
    (3.0)

    Adverse Events

    Time Frame Adverse event data were collected for the duration each subject was enrolled in the study, one day.
    Adverse Event Reporting Description
    Arm/Group Title Experimental
    Arm/Group Description Pelvic floor support device to treat refractory constipation. "the Bottom's Up": A modified toilet seat that supports the perineum, preventing excessive pelvic floor descent and laxity which can cause constipation.
    All Cause Mortality
    Experimental
    Affected / at Risk (%) # Events
    Total 0/12 (0%)
    Serious Adverse Events
    Experimental
    Affected / at Risk (%) # Events
    Total 0/12 (0%)
    Other (Not Including Serious) Adverse Events
    Experimental
    Affected / at Risk (%) # Events
    Total 0/12 (0%)

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    All Principal Investigators ARE employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Amy Foxx-Orenstein
    Organization Mayo Clinic
    Phone 480-301-6990
    Email foxx-orenstein.amy@mayo.edu
    Responsible Party:
    Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT02419924
    Other Study ID Numbers:
    • 14-009864
    First Posted:
    Apr 17, 2015
    Last Update Posted:
    Sep 2, 2020
    Last Verified:
    Aug 1, 2020